20 Nov National Institute for Health and Clinical Excellence Maintains Previous Recommendation for EXOGEN Ultrasound Bone Healing System
National Institute for Health and Clinical Excellence Maintains Previous Recommendation for EXOGEN Ultrasound Bone Healing System
Bioventus has received notice of the National Institute for Health and Clinical Excellence (NICE) concerning the indication of EXOGEN for treatment of long bone fractures with nonunion.
EXOGEN uses low intensity pulsed ultrasound (LIPUS) to stimulate the body’s bone healing process and to promote the fracture healing. It has 86% healing rate in nonunion and offers a 38% faster healing time of fresh fractures.
After reviewing a large body of clinical evidence, NICE sustains its recommendation to use EXOGEN for the treatment of long bone nonunions. NICE defines a nonunion as a fracture that does not heal after nine months.
Additionally, with the 25% increase of surgical costs since 2013, EXOGEN has demonstrated to double its cost savings per patient from £1,164 to £2,407.
The indication of EXOGEN is supported by multiple Level 1 studies that demonstrate its positive effects on fracture healing and the advantages of the LIPUS technology.